Application of percutaneous vertebroplasty and percutaneous kyphoplasty in treating Kümmell’s patients with different stages and postural correction status

医学 后凸 Oswestry残疾指数 经皮椎体成形术 经皮 可视模拟标度 外科 生活质量(医疗保健) 前瞻性队列研究 阶段(地层学) 背痛 放射科 椎体 骨水泥 腰痛 水泥 射线照相术 替代医学 考古 护理部 古生物学 病理 历史 生物
作者
Haiming Yu,Yizhong Li,Xuedong Yao,Jianping Lin,Yuancheng Pan,Huafeng Zhuang,Pei‐Wen Wang
出处
期刊:Expert Review of Medical Devices [Informa]
卷期号:17 (4): 357-364 被引量:10
标识
DOI:10.1080/17434440.2020.1736039
摘要

Objectives: To compare the effects of percutaneous vertebroplasty (PVP) or percutaneous kyphoplasty (PKP) in treating Kümmell's disease (KD) patients.Methods: This prospective cohort study involved 19 KD patients (20 involved vertebrae). The surgical selection was dependent on clinical stages and postural correction status. The status of vertebral reduction, amount of cement injection, and amount of cement leakage during the surgery were recorded. The anterior vertebral height and kyphotic angle were measured by X-ray scan. The degree of low back pain and the quality of life were assessed by the visual analog scale and Oswestry disability index, respectively.Results: On the third-day post-operation and the last follow-up, anterior vertebral height was increased, kyphosis angle was reduced, low back pain was relieved, and life quality was improved in both groups compared with pre-operation. There was no significant difference between the two groups in cement amount, cement leakage rate, vertebral height correction, and kyphotic correction angle. The nerve function of stage III patients with spinal cord injury was improved from a Frankel grade D to E.Expert Opinion: PVP and PKP could be used in treating KD patients, and the surgical selection could be dependent on the clinical stages and status of postural correction.Conclusion: PVP and PKP could be used in treating KD patients, and the surgical selection could be dependent on the clinical stages and status of postural correction.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
Xxy发布了新的文献求助10
1秒前
1秒前
于文志发布了新的文献求助10
1秒前
科研通AI6应助悠悠采纳,获得30
2秒前
科研通AI6应助悠悠采纳,获得10
2秒前
活泼的采枫完成签到,获得积分10
2秒前
上官若男应助悠悠采纳,获得10
2秒前
丘比特应助悠悠采纳,获得10
2秒前
NexusExplorer应助悠悠采纳,获得10
2秒前
科研通AI6应助悠悠采纳,获得30
2秒前
科研通AI6应助悠悠采纳,获得10
2秒前
科研通AI6应助悠悠采纳,获得10
2秒前
科研通AI6应助悠悠采纳,获得30
2秒前
HJJHJH发布了新的文献求助20
3秒前
aki应助走四方采纳,获得10
3秒前
zhang完成签到 ,获得积分10
3秒前
3秒前
浮游应助空耳大师采纳,获得10
3秒前
4秒前
4秒前
真真发布了新的文献求助10
4秒前
hrbykdxly完成签到,获得积分10
5秒前
ALARIC发布了新的文献求助10
5秒前
科研通AI6应助suicone采纳,获得10
6秒前
7秒前
小蘑菇应助宋二庆采纳,获得10
7秒前
熊猫侠完成签到,获得积分20
7秒前
直率不乐发布了新的文献求助10
8秒前
脑洞疼应助南渡北归采纳,获得10
8秒前
EvaHo完成签到,获得积分10
9秒前
张花花完成签到,获得积分20
10秒前
11秒前
所所应助早睡早起会魔法采纳,获得30
11秒前
刻苦的青争完成签到 ,获得积分10
11秒前
领导范儿应助llynvxia采纳,获得10
12秒前
瓦学弟的妈妈完成签到 ,获得积分10
12秒前
12秒前
小米椒完成签到 ,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
List of 1,091 Public Pension Profiles by Region 1001
The Antibodies, Vol. 2,3,4,5,6 1000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 1000
On the application of advanced modeling tools to the SLB analysis in NuScale. Part I: TRACE/PARCS, TRACE/PANTHER and ATHLET/DYN3D 500
L-Arginine Encapsulated Mesoporous MCM-41 Nanoparticles: A Study on In Vitro Release as Well as Kinetics 500
Virus-like particles empower RNAi for effective control of a Coleopteran pest 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5461411
求助须知:如何正确求助?哪些是违规求助? 4566402
关于积分的说明 14305053
捐赠科研通 4492112
什么是DOI,文献DOI怎么找? 2460760
邀请新用户注册赠送积分活动 1449996
关于科研通互助平台的介绍 1425619